Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Isoniazid 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrazine |
Inferred relationship |
Some |
|
Isoniazid 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrazine |
Inferred relationship |
Some |
|
Isoniazid 50mg/5mL s/f oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrazine |
Inferred relationship |
Some |
|
Isoniazid 25mg/mL injection solution 2mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrazine |
Inferred relationship |
Some |
|
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrazine |
Inferred relationship |
Some |
|
Product containing precisely isoniazid 150 milligram and rifampicin 300 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrazine |
Inferred relationship |
Some |
|
Product containing isoniazid and rifampicin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrazine |
Inferred relationship |
Some |
|
Product containing isoniazid and pyrazinamide and rifampicin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrazine |
Inferred relationship |
Some |
|
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrazine |
Inferred relationship |
Some |
|
Hydrazide antituberculosis drug |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrazine |
Inferred relationship |
Some |
|
Product containing isoniazid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrazine |
Inferred relationship |
Some |
|
Isoniazid 50mg/5mL oral syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrazine |
Inferred relationship |
Some |
|
Isoniazid 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrazine |
Inferred relationship |
Some |
|
Isoniazid + pyrazinamide + rifampin 50mg/300mg/120mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrazine |
Inferred relationship |
Some |
|
Isoniazid 150 mg and rifampicin 300 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrazine |
Inferred relationship |
Some |
|
Isoniazid 100mg/mL injection solution 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrazine |
Inferred relationship |
Some |
|
Ethambutol hydrochloride+isoniazid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrazine |
Inferred relationship |
Some |
|
Eltrombopag (substance) |
Is a |
False |
Hydrazine |
Inferred relationship |
Some |
|
Phenelzine (substance) |
Is a |
False |
Hydrazine |
Inferred relationship |
Some |
|
Isocarboxazid (substance) |
Is a |
False |
Hydrazine |
Inferred relationship |
Some |
|
Hydrazine sulfate |
Is a |
False |
Hydrazine |
Inferred relationship |
Some |
|
Benserazide (substance) |
Is a |
False |
Hydrazine |
Inferred relationship |
Some |
|
Hydrazide antituberculosis agent |
Is a |
False |
Hydrazine |
Inferred relationship |
Some |
|
Iproniazid (substance) |
Is a |
False |
Hydrazine |
Inferred relationship |
Some |
|
Pasiniazid (substance) |
Is a |
False |
Hydrazine |
Inferred relationship |
Some |
|
1,2-diphenylhydrazine (substance) |
Is a |
False |
Hydrazine |
Inferred relationship |
Some |
|
Hydrazine sulfate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Hydrazine |
Inferred relationship |
Some |
|
Product containing hydrazine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrazine |
Inferred relationship |
Some |
1 |
Hydrazine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrazine |
Inferred relationship |
Some |
1 |
Hydralazine (substance) |
Is a |
False |
Hydrazine |
Inferred relationship |
Some |
|
Hydralazine hydrochloride |
Is a |
False |
Hydrazine |
Inferred relationship |
Some |
|